+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
Metastatic Uveal Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Uveal Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Metastatic Pancreatic Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Pancreatic Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Metastatic Melanoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Melanoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 250 Pages
  • Global
From
Metastatic HER2 Positive Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic HER2 Positive Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mantle Cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

Mantle Cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Malignant Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Soft Tissue Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cervical Intraepithelial Neoplasia- Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Uveal Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Uveal Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CDK9 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CDK9 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Urothelial Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Transitional Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Transitional Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Glioblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Glioblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Primary Myelofibrosis- Pipeline Insight, 2025 - Product Thumbnail Image

Primary Myelofibrosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Marginal Zone Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Marginal Zone Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2025 - Product Thumbnail Image

Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Neuroblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more